Skip to Content


Zamansky LLC is investigating Cell Therapeutics Inc. (NASDAQ: CTIC) “CTIC” or the “Company”) for potential breaches of duties owed to shareholders.  CTIC is a company engaged in developing cancer treatment drugs.  Its stock price is down 75% this year alone.

On December 18, 2012, Seeking Alpha published an article entitled “CTIC: Strong ‘Sell’ Therapeutics?” which raised numerous questionable past and present activities.  Seeking Alpha has raised questions concerning CTIC’s private financing deal with Socius Capital, its CEO compensation and current financing activities.  Seeking Alpha also report on CTIC’s settlement recently of its shareholder lawsuit that was filed back in 2010.

Zamansky is investigating CTIC for breaches of duties owed towards investors and shareholders who own CTIC stock.  If you are a CTIC shareholder or investor who suffered a loss, and wish to discuss your legal rights, please contact Jake Zamansky at 212 742-1414, or by email at